Transgenic plants as factories for biopharmaceuticals

Nature Biotechnology

Volumn 18, Issue 11, 2000, Pages 1151-1155

  Giddings, Glynis ^a   Allison, Gordon ^a   Brooks, Douglas ^a   Carter, Adrian ^a  

^a ABERYSTWYTH UNIVERSITY   (United Kingdom)

Author keywords

Antibodies; Biopharmaceuticals; Edible vaccine; GM crops; Production systems

Indexed keywords

ANTIBODY; GLUCOSYLCERAMIDASE; HIRUDIN; VACCINE;

AGRICULTURE; ARTICLE; BEAN; BIOTECHNOLOGY; CANADA; COST CONTROL; DRUG RESEARCH; GENE EXPRESSION SYSTEM; NONHUMAN; PEA; POTATO; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; TOBACCO; TRANSGENIC PLANT; VACCINE PRODUCTION;

ANTIBODIES; DRUG INDUSTRY; GENETIC ENGINEERING; GLUCOSYLCERAMIDASE; HIRUDINS; PEPTIDES; PLANTS, GENETICALLY MODIFIED; PROTEIN BIOSYNTHESIS; RECOMBINANT PROTEINS; SAFETY; VACCINES;

NICOTIANA TABACUM; PHASEOLUS (ANGIOSPERM); PISUM SATIVUM; SOLANUM TUBEROSUM;

EID: 0033758021     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/81132     Document Type: Article

References (57)

1. Plant expression systems for the production of vaccines
2. Expression of human blood proteins in transgenic plants: The cytokine GM-CSF as a model protein
3. Comparison of host systems for the production of recombinant proteins
4. The production of recombinant proteins in plants
5. Molecular farming in plants: Achievements and prospects
6. Production of biologically active hirudin in plant seeds using oteosin partitioning
7. Production of recombinant proteins in transgenic plants: Practical considerations
8. Antibody production and engineering in plants
9. The production of antibodies in plants
10. N-glycosylation of a mouse IgG expressed in transgenic tobacco plants
11. High-level and stable accumulation of single-chain Fv antibodies in plant storage organs
12. Production of correctly processed human serum albumin in transgenic plants
13. Bioproduction of human enzymes in transgenic tobacco
14. Foreign protein production in plant tissue cultures
15. A review of oral vaccination with transgenic vegetables
16. Production of novel compounds in higher plants by transfection with RNA viral vectors
17. Production of antibodies in transgenic plants
18. Rapid, high-level expression of biologically active alpha-trichosanthin in transfected plants by an RNA viral vector
19. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants
20. Molecular farming in plants: Oilseeds as vehicles for the production of pharmaceutical proteins
21. A new tobacco mosaic virus vector and its use for the systematic production of angiotensin-I-converting enzyme inhibitor in transgenic tobacco and tomato
22. Expression of the rabies virus glycoprotein in transgenic tomatoes
23. Edible plant vaccines
24. Plant-derived vaccine protects target animals against a viral disease
25. Plants as bioreactors
26. Enkephalines produced in transgenic plants using modified 2S storage proteins
27. Transgenic Brassica carinata as a vehicle for the production of recombinant proteins in seeds
28. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato
29. Transgenic plants expressing autoantigens fed to induce oral immune tolerance
30. Transgenic plant technology is entering the era of metabolic engineering
31. Potato tubers as a biofactory for recombinant antibodies
32. Transgenic rice (Oryza sativa) endosperm expressing daffodil (Narcissus pseudonarcissus) phytoene synthase accumulates phytoene, a key intermediate of provitamin a biosynthesis
33. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies
34. Commercial production of aprotinin in transgenic maize seeds
35. Genetic elements of plant viruses as tools for genetic engineering
36. Use of plant viruses for delivery of vaccine epitopes
37. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus
38. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice
39. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization
40. Expressing antibodies in plants for immunotherapy
41. Transgenic plants for therapeutic proteins: Linking upstream and downstream strategies
42. Plant-based production of xenogenic proteins
43. Immunogenicity of transgenic plant-derived hepatitis B surface antigen
44. Production of hepatitis B surface antigen in transgenic plants for oral immunization
45. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes
46. Efficacy of a food plant-based oral cholera toxin B subunit vaccine
47. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans
48. Antibody production by molecular farming in plants
49. Occurrence, fate and effects of pharmaceutical substances in the environment - A review
50. Human haemoglobin from transgenic tobacco
51. Triple helix assembly and processing of human collagen produced in transgenic tobacco plants
52. Increased nutritive value of transgenic potato by expressing a nonallergenic seed albumin gene from Amaranthus hypochondriacus
53. Reducing transgene escape routes